SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Clinical trial NCT04150042 · RECRUITING

Trial details

NCT number: NCT04150042
Sponsor: General Oncology, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Metastatic BRCA1 Mutation BRCA2 Mutation Pancreatic Acinar Cell Carcinoma Pancreatic Ductal Adenocarcinoma Pancreatic Cancer Metastatic Pancreatic Cancer Metastatic Pancreatic Ductal Adenocarcinoma Breast Cancer Metastatic Breast Cancer Stage IV Pancreatic Cancer Stage IV HER2-negative Breast Cancer

Start date: 2021-01-13
Primary completion: 2028-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.